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1. Introduction 
It is currently thought that cyclic AMP in an intra- 
cellular mediator of many of the effects of TSH on 
the thyroid gland [l] . This hypothesis is primarily 
supported by the observations that TSH increases the 
levels of cyclic AMP in thyroid tissue [2,3], cyclic 
AMP stimulates l-‘4C-glucose oxidation in beef 
thyroid homogenates [4], and dibutyryl cyclic AMP, 
a cyclic AMP analogue, mimics some of the effects of 
TSH in the thyroid gland [ 1,5,6]. In all these studies, 
however, the maximal response produced by dibutyryl 
cyclic AMP is in general less than that produced by 
TSH itself [7] and, in some species, qualitative differ- 
ences between the effects of TSH and dibutyryl 
cyclic AMP also exist [l] . 
The failure of dibutyryl cyclic AMP to completely 
mimic TSH action, suggests that some of the TSH 
effects may be unrelated to the cyclic nucleotide. 
However, other nucleotides, such as cyclic GMP, have 
also been reported to be involved in the intracellular 
mediation of hormonal responses [8,9] . In order to 
clarify this possibility, it was considered interesting 
to investigate what relationship, if any, exists between 
TSH, dibutyryl cyclic AMP and dibutyryl cyclic GMP 
by comparing the ability of the two latter nucleotides 
to produce some TSH-like effects in hog-thyroid slices. 
2. Materials and methods 
Dibutyryl cyclic AMP and dibutyryl cyclic GMP 
were kindly and generously supplied from Boehringer, 
Mannheim GmbH (Mannheim). Thyroid stimulating 
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hormone (TSH) (2 U/mg) was a gift from the 
Endocrine Study Section, National Institutes of 
Health, Bethesda (USA). The sources of the other 
materials used have been previously described [lo] . 
Glucose oxidation, phospholipid synthesis, iodide 
accumulation and colloid droplet formation were 
measured as previously described [ 11, 121 . RNA and 
protein synthesis were measured as described else- 
where [ 131 . In all studies, fresh thyroid slices were 
used. Thyroid glands, obtained from the local 
abbatoir, were sliced with a Stadie-Riggs microtome, 
washed in KRB buffer and incubated under the 
experimental conditions indicated in the tables. 
3. Results and discussion 
Since the thyroid response to TSH and dibutyryl 
cyclic AMP vary widely from animal to animal, the 
effects of TSH, dibutyryl cyclic AMP and dibutyryl 
cyclic GMP were tested on the same gland in each 
experiment. 
Table 1 shows that dibutyryl cyclic AMP, like 
TSH, stimulates the incorporation of 32Pi into total 
phospholipids, while dibutyryl cyclic GMP has only 
a slight effect. The effect of the cyclic nucleotides is 
not due to the presence of the butyrate group in the 
molecule since butyrate alone has no effect. When 
dibutyryl cyclic GMP was tested on l-‘4C-glucose 
oxidation, and 1311 uptake, it failed to stimulate these 
two metabolic activities in thyroid tissue at all con- 
centrations used. On the other hand, TSH and 
dibutyryl cyclic AMP are both active in this respect. 
In contrast, TSH, dibutyryl cyclic AMP and dibutyryl 
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Table 1 
Effects of TSH, dibutyryl cyclic AMP and dibutyryl cyclic GMP on phospholipid synthesis, glucose oxidation, iodide accumula- 
tion and 3H-leucine incorporation into total proteins, in hog-thyroid slices. 
Compound 
Concn. 
(PM) 
32P incorporation 
into ph,_--‘-“-“_ “sprlullplos 
._,I__\ 
(cpm/mg/m) 
14COa produced _ 
I...~.. I_._,.~ \ (cpm/mg/nr) ( 
1311 uptake 
‘cpm/g/min) 
3H-leucine 
incorporated into 
total proteins 
(cpm/mg/hr) 
None - 45+2 20+1 13,000 
DBcAMP 100 50fl 28fl 15,000 
DBcAMP 200 57f3 25+2 _ 
DBcAMP 500 63f5 24f2 18,000 
DBcGMP 50 44f2 20f2 13,000 
DBcGMP 100 46f3 21+1 14,000 
DBcGMP 200 48?3 20+2 13,500 
DBcGMP 500 49f2 22*2 13,000 
Butyrate 200 45&l 2052 13,100 
TSH 100 mu/ml 113+7 39f3 18,000 
2,000 
3,700 
2,900 
2,700 
3,000 
4,600 
4,300 
2,700 
- 
3,140 
For studies on phospholipid synthesis, each slice was incubated 2 hr in 1 ml of KRB buffer containing 1 mg of albumin, 1 mg of 
glucose and 0.5 PCi of 32Pi. For studies on glucose oxidation each slice was incubated 1 hr in 1 ml of KRB buffer, containing 1 
mg of albumin, 1 mg of glucose and 0.3 PCi of l-14Cglucose. In the iodide accumulation studies, the slices were individually in- 
cubated in 3 ml of KRB buffer containing 3 mg of albumin, 3 mg of glucose and, where indicated, TSH, dibutyryl cyclic AMP and 
dibutyryl cyclic GMP. All these compounds were added at the start of the incubation, whereas 13’1 was added 20 min before the 
incubation was terminated. For the experiments on the 3H-leucine incorporation into total proteins, the slices were individually 
incubated for 1 hr in 1 ml of Eagle’s medium without stable leucine but in the presence of radioactive leucine (10 PCi). All ex- 
periments were repeated at least five times; typical results are reported, each value represents the average obtained from four 
slices fS.E. 
cyclic GMP are all active in stimulating the incorpora- It has been previously reported that dibutyryl cyclic 
tion of 3H-leucine into total thyroid proteins. Among AMP, like TSH, is able to stimulate RNA synthesis 
these compounds, dibutyryl cyclic GMP, whose op- [ 141. We have now compared the effect of dibutyryl 
timal activation occurs at a concentration of 100-200 cyclic GMP to that of TSH and dibutyryl cyclic AMP 
/JM is the most effective. Higher concentrations of this on the time-course of incorporation of 32Pi into RNA. 
nucleotide abolish the stimulatory effect. As illustrated in table 2, it is evident that the stimula- 
Table 2 
Effects of TSH, dibutyryl cyclic and dibutyryl cyclic GMP on RNA synthesis and colloid droplet formation in hog-thyroid slices. 
Compound 
Cont. 
OcM) 
32Pi incorporation into RNA (cpm/mg tissue) 
30 min 60 min 120 min 
None - 1,700 3,900 6,300 
DBcAMP 506 1,770 4,500 10,000 
DBcGMP 500 1,900 4,100 7,600 
TSH 100 mu/ml 2,400 5,300 11,000 
For experiments on RNA synthesis, each slice was incubated in 1 ml of KRB buffer, containing 1 mg of albumin , 1 mg of glucose 
and 0.5 &i of 32Pi. 
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tion by dibutyryl cyclic GMP is only slight, as com- 
pared to that of dibutyryl cyclic AMP, which is almost 
as effective as TSH. Furthermore, while TSH is active 
at an earlier time, both nucleotides need a longer in- 
cubation period. This delayed effect is probably due 
to their slower intracellular penetration. However, 
the effects of both dibutyryl cyclic AMP and dibutyryl 
cyclic GMP, as was observed in the case of 32 Pi in- 
corporation into phospholipids (see table l), show 
their maximum effect at a concentration of 500 PM. 
Below this concentration, the degree of stimulation 
is much lower, while at higher concentrations the in- 
corporation is not influenced any further. 
A more specific response to the in vitro addition 
of TSH appears to be the stimulation of the forma- 
tion of intracellular colloid droplets [ 141 . Again, 
when tested for this effect, dibutyryl cyclic GMP 
shows a different behaviour as compared to dibutyryl 
cyclic AMP and TSH. In fact, we have observed that 
these latter compounds stimulate droplet formation, 
whereas this morphological effect is absent when 
dibutyryl cyclic GMP is added to the tissue. 
The above results, while further supporting the 
hypothesis that cyclic AMP is the intracellular medi- 
ator of TSH action, suggest, on the other hand, that 
cyclic GMP might not have the same role. Nevertheless, 
it is possible that cyclic GMP is involved in the control 
of some metabolic activity of thyroid gland such as 
protein synthesis. 
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